Humana Divests Interest in End-of-Life Provider Gentiva Valued at $900M

Humana divests interest in end-of-life provider Gentiva valued at $900M

The insurer is offloading its interest in the massive end-of-life care provider to an undisclosed group of investors, amid widespread concern about private investors’ activity in healthcare.

Humana To Divest End-Of-Life Care Business For $900 Million

Humana, one of the largest U.S. sellers of Medicare Advantage insurance for older adults, will divest its stake in a provider of end-of-life services for $900 million.

Humana Announces Agreement to Divest Minority Interest in Gentiva

Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with a consortium of investors to